GetTopicDetailResponse(id=0acb306645, topicName=AXL抑制劑, introduction=AXL抑制劑, content=null, image=null, comments=1, allHits=345, url=https://h5.medsci.cn/topic?id=3066, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=96448, tagList=[TagDto(tagId=96448, tagName=AXL抑制劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1780258, encodeId=25641e8025830, content=<a href='/topic/show?id=0acb306645' target=_blank style='color:#2F92EE;'>#AXL抑制劑#</a>, objectTitle=酪氨酸激酶受體AXL抑制劑Bemcentinib聯(lián)合Keytruda，用于晚期非小細(xì)胞肺癌的2期臨床達(dá)到終點(diǎn), objectType=article, longId=182592, objectId=625c1825922c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625c1825922c, replyNumber=0, likeNumber=63, createdTime=2020-06-17, rootId=0, userName=pcw106, userId=a98f453, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625c1825922c, moduleTitle=酪氨酸激酶受體AXL抑制劑Bemcentinib聯(lián)合Keytruda，用于晚期非小細(xì)胞肺癌的2期臨床達(dá)到終點(diǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=625c1825922c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
